Laura B. Todaro

773 total citations
26 papers, 514 citations indexed

About

Laura B. Todaro is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Laura B. Todaro has authored 26 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Genetics. Recurrent topics in Laura B. Todaro's work include Cancer Cells and Metastasis (6 papers), Estrogen and related hormone effects (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Laura B. Todaro is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Estrogen and related hormone effects (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Laura B. Todaro collaborates with scholars based in Argentina, United States and Cuba. Laura B. Todaro's co-authors include Elisa Bal de Kier Joffé, Damián E. Berardi, Alejandro J. Urtreger, Lydia Puricelli, José Lastiri, Marina Simian, Eugenia Sacerdote de Lustig, Marı́a Guadalupe Pallotta, Mirta Varela and Gabriel L. Fiszman and has published in prestigious journals such as Scientific Reports, Cancer Letters and Neurobiology of Disease.

In The Last Decade

Laura B. Todaro

26 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura B. Todaro Argentina 16 287 173 110 69 51 26 514
Carrie D. House United States 15 520 1.8× 184 1.1× 172 1.6× 38 0.6× 25 0.5× 30 766
Nicolas Currier United States 9 381 1.3× 147 0.8× 69 0.6× 43 0.6× 16 0.3× 11 649
Cécile Thirant France 13 408 1.4× 141 0.8× 170 1.5× 17 0.2× 49 1.0× 18 594
Phillip J. Wilder United States 17 747 2.6× 161 0.9× 116 1.1× 97 1.4× 20 0.4× 29 1.0k
Catarina Grandela Netherlands 14 702 2.4× 218 1.3× 121 1.1× 68 1.0× 70 1.4× 20 915
Marie‐Josée Demers Canada 10 280 1.0× 135 0.8× 92 0.8× 35 0.5× 22 0.4× 12 507
Jason Catania United States 10 508 1.8× 278 1.6× 98 0.9× 47 0.7× 68 1.3× 11 697
Hemant Varma United States 12 305 1.1× 122 0.7× 57 0.5× 43 0.6× 33 0.6× 36 625
Pítia Flores Ledur Brazil 10 217 0.8× 99 0.6× 61 0.6× 17 0.2× 46 0.9× 11 441
Anna Lina Cavallo Italy 8 358 1.2× 67 0.4× 45 0.4× 38 0.6× 29 0.6× 9 507

Countries citing papers authored by Laura B. Todaro

Since Specialization
Citations

This map shows the geographic impact of Laura B. Todaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura B. Todaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura B. Todaro more than expected).

Fields of papers citing papers by Laura B. Todaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura B. Todaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura B. Todaro. The network helps show where Laura B. Todaro may publish in the future.

Co-authorship network of co-authors of Laura B. Todaro

This figure shows the co-authorship network connecting the top 25 collaborators of Laura B. Todaro. A scholar is included among the top collaborators of Laura B. Todaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura B. Todaro. Laura B. Todaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Berardi, Damián E., Stéfano M. Cirigliano, Alexis Edelstein, et al.. (2021). All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression. Scientific Reports. 11(1). 6044–6044. 7 indexed citations
3.
Berardi, Damián E., et al.. (2020). Protein Kinase C Alpha (PKCα) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (RARβ) activation in mammary cancer cells. Journal of Cancer Research and Clinical Oncology. 146(12). 3241–3253. 10 indexed citations
4.
Todaro, Laura B., et al.. (2020). Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation. European Journal of Cell Biology. 99(6). 151096–151096. 27 indexed citations
5.
Berardi, Damián E., et al.. (2017). Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture. Journal of Cellular Biochemistry. 119(2). 1381–1391. 42 indexed citations
6.
Cirigliano, Stéfano M., Damián E. Berardi, Elisa Bal de Kier Joffé, et al.. (2017). The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines. Cancer Cell International. 17(1). 42–42. 12 indexed citations
7.
Brantley, Eileen, Damián E. Berardi, Marina Simian, et al.. (2016). AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity. Cancer Letters. 376(1). 53–61. 34 indexed citations
8.
Berardi, Damián E., et al.. (2016). Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway. Cancer Research and Treatment. 49(4). 869–879. 15 indexed citations
9.
Berardi, Damián E., et al.. (2015). Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid. Cellular Oncology. 38(4). 289–305. 15 indexed citations
10.
Berardi, Damián E., Stéfano M. Cirigliano, Elisa Bal de Kier Joffé, et al.. (2015). PKCδ Inhibition Impairs Mammary Cancer Proliferative Capacity But Selects Cancer Stem Cells, Involving Autophagy. Journal of Cellular Biochemistry. 117(3). 730–740. 22 indexed citations
11.
Berardi, Damián E., et al.. (2013). Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate. Breast Cancer Research and Treatment. 142(3). 537–548. 29 indexed citations
12.
13.
Todaro, Laura B., et al.. (2011). Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?. Current Pharmaceutical Biotechnology. 12(11). 1891–1899. 22 indexed citations
14.
Berardi, Damián E., et al.. (2011). Autophagy: Friend or Foe in Breast Cancer Development, Progression, and Treatment. International Journal of Breast Cancer. 2011. 1–7. 44 indexed citations
15.
Berardi, Damián E., et al.. (2010). Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs. Breast Cancer Research and Treatment. 126(3). 577–587. 24 indexed citations
16.
Joffé, Elisa Bal de Kier, et al.. (2010). The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer. Molecular Carcinogenesis. 49(4). 386–397. 19 indexed citations
17.
Todaro, Laura B., et al.. (2009). Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model. Breast Cancer Research and Treatment. 118(3). 469–480. 21 indexed citations
18.
Todaro, Laura B., Silvia Christiansen, Mirta Varela, et al.. (2007). Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors. Journal of Neuro-Oncology. 83(2). 135–144. 35 indexed citations
19.
Todaro, Laura B., Lydia Puricelli, Marı́a Guadalupe Pallotta, et al.. (2004). Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type. Neurobiology of Disease. 15(2). 387–393. 48 indexed citations
20.
Confalonieri, Viviana A., Andrea S. Sequeira, Laura B. Todaro, & Juan C. Vilardi. (1998). Mitochondrial DNA and phylogeography of the grasshopper Trimerotropis pallidipennis in relation to clinal distribution of chromosome polymorphisms. Heredity. 81(4). 444–452. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carrie D. House Breakdown of academic impact, for papers by Nicolas Currier Breakdown of academic impact, for papers by Cécile Thirant Breakdown of academic impact, for papers by Phillip J. Wilder Breakdown of academic impact, for papers by Catarina Grandela Breakdown of academic impact, for papers by Marie‐Josée Demers Breakdown of academic impact, for papers by Jason Catania Breakdown of academic impact, for papers by Hemant Varma Breakdown of academic impact, for papers by Pítia Flores Ledur Breakdown of academic impact, for papers by Anna Lina Cavallo
Rankless by CCL
2026